Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patients.

Autor: Regina Juanbeltz, Iván Martínez-Baz, Ramón San Miguel, Silvia Goñi-Esarte, Juan Manuel Cabasés, Jesús Castilla

Publikováno v: PLoS ONE, Vol 13, Iss 10, p e0205277 (2018)

BACKGROUND:Direct-acting antivirals (DAA) have demonstrated high efficacy to achieve sustained virological response (SVR) in chronic hepatitis C patients. We aim to assess the change in health-related quality of life (HRQoL) among patients successful

Externí odkaz: https://doaj.org/article/378f9fd242bf417ab7d4481be1f9ab08

Modification of liver fibrosis, glucose and lipid profile after hepatitis C virus clearance with direct-acting antiviral agents

Autor: José Manuel Zozaya, Juan Isidro Úriz, José Ignacio Herrero, Silvia Goñi Esarte, Regina Juanbeltz, Jesús Castilla

Publikováno v: Gastroenterología y Hepatología. 43:248-255

There is little information on whether direct-acting antiviral (DAA) treatment can improve liver fibrosis or change glucose and lipid profile in patients with chronic hepatitis C (CHC). We aimed to evaluate the impact of sustained virologic response

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73466d16a9299e7c068786899f307c1f
https://doi.org/10.1016/j.gastrohep.2019.03.017

1ISG-001 Health utilities in chronic hepatitis C patients one year after successful treatment with direct-acting antivirals

Autor: R San Miguel, I Herrero, Silvia Goñi-Esarte, Jesús Castilla, Iván Martínez-Baz, B Larrayoz, Regina Juanbeltz, José Manuel Zozaya, M Sarobe, María Rivero

Publikováno v: Section 1: Introductory Statements and Governance.

Background Health utilities are measures of quality of life, which are used to obtain quality-adjusted life years in pharmacoeconomic evaluations. A short-term utility improvement has been recently reported after hepatitis C viral clearance, although

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1fc2df70defb81b9f82079f41e537166
https://doi.org/10.1136/ejhpharm-2019-eahpconf.1

Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patients

Autor: Jesús Castilla, Ramón San Miguel, Silvia Goñi-Esarte, Regina Juanbeltz, Iván Martínez-Baz, Juan M. Cabasés

Publikováno v: PLoS ONE
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
instname
Academica-e: Repositorio Institucional de la Universidad Pública de Navarra
Universidad Pública de Navarra
PLoS ONE, Vol 13, Iss 10, p e0205277 (2018)

Background. Direct-acting antivirals (DAA) have demonstrated high efficacy to achieve sustained virological response (SVR) in chronic hepatitis C patients. We aim to assess the change in healthrelated quality of life (HRQoL) among patients successful

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff5884df1dc206139ac3fb35d66e231d
http://europepmc.org/articles/PMC6177189

Rescate con rituximab en paciente con liquen plano esofágico refractario

Autor: Francisco Javier Jiménez Pérez, Juan Carrascosa Gil, Silvia Goñi Esarte, Juan José Vila Costas, María Luz Almendral López, David Ruiz-Clavijo García, Antonio Arin Letamendia

Publikováno v: Gastroenterología y Hepatología. 36:264-267

Esophageal lichen planus (ELP) is a rare condition with unknown prevalence that can sometimes be underestimated due to the subtle and nonspecific findings of diagnostic workup. Oral lesions rarely extend to the esophageal mucosa, but when they do, th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9bf1b6fbda8e204da4026c136d4c8222
https://doi.org/10.1016/j.gastrohep.2012.07.004